Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function.
发现一种潜在的血液恶性肿瘤疗法：选择性强效的 HDAC7 PROTAC 降解剂，靶向非酶功能
期刊:Acta Pharmaceutica Sinica B
影响因子:14.6
doi:10.1016/j.apsb.2025.01.021
Jin Yuheng, Qi Xuxin, Yu Xiaoli, Cheng Xirui, Chen Boya, Wu Mingfei, Zhang Jingyu, Yin Hao, Lu Yang, Zhou Yihui, Pang Ao, Lin Yushen, Jiang Li, Shi Qiuqiu, Geng Shuangshuang, Zhou Yubo, Yao Xiaojun, Li Linjie, Duan Haiting, Che Jinxin, Cao Ji, He Qiaojun, Dong Xiaowu
